“Can Rare Cancer Drugs Expect Sales in Japan?: A Prescription Pattern Analysis of Drugs for Chronic Myelogenous Leukemia and Neuroendocrine Tumor”, regsci, vol. 7, pp. 1–9, Feb. 2019, doi: 10.21423/JRS-V07SHIBATA.